TrialCancer2017

7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.

Bing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.